Does CABOZANTINIB S-MALATE Cause Decreased appetite? 4,076 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 4,076 reports of Decreased appetite have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 10.4% of all adverse event reports for CABOZANTINIB S-MALATE.
4,076
Reports of Decreased appetite with CABOZANTINIB S-MALATE
10.4%
of all CABOZANTINIB S-MALATE reports
233
Deaths
751
Hospitalizations
How Dangerous Is Decreased appetite From CABOZANTINIB S-MALATE?
Of the 4,076 reports, 233 (5.7%) resulted in death, 751 (18.4%) required hospitalization, and 34 (0.8%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
Death (2,504)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
ETANERCEPT (3,201)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Decreased appetite Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE